Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement
Yi Xu(Loma Linda University), Jiang F. Zhong(University of Southern California), Kevin R. Kelly(The University of Texas Health Science Center at San Antonio), Jane Xu(Loma Linda University), Saied Mirshahidi(Loma Linda University), Fengzhu Sun(University of Southern California), Kaijin Wu(University of Southern California), Shengwen Calvin Li(Massachusetts Institute of Technology), Xi Zhang(Army Medical University), Julian Olea(University of Southern California), Qin Wen(Army Medical University), Jeffrey Xiao(Loma Linda University), Ruihao Huang(Army Medical University), Hisham Abdel‐Azim(University of Southern California), Cristina Maria Ghiuzeli(University of Washington), Durga Cherukuri(Loma Linda University), Huynh Cao(Loma Linda University), Xiaoqi Wang(Army Medical University), Qian Liu(Sun Yat-sen University), Yan Liu(Chongqing Medical University), Xuelian Chen(University of Southern California), David J. Baylink(Loma Linda University), Esther G Chong(Loma Linda University), Dadrastoussi Homa(University of Southern California), Mark E. Reeves(Loma Linda University)
Cited by 3
Related Papers
Src Tyrosine Kinases, Gα Subunits, and H-Ras Share a Common Membrane-anchored Scaffolding Protein, Caveolin
|Journal of Biological Chemistry|1996|771
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
|Nature Reviews Clinical Oncology|2018|236